Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TISTA SYNSSENTER AS
AS
Active
Org 929263677
Walkers Gate 4, 1771 Halden
Retail sale of medical and orthopaedic goods · NACE 4774
Est. 2022
8 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 14,7M
+7% vs 2024
EBITDA margin
8.3%
+10% vs 2024
Equity ratio
30.3%
Financial strength
Net profit 2025
NOK 613K
+12% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 14,7M
+7%
EBITDA
NOK 1,2M
+10%
Net profit
NOK 613K
+12%
Total assets
NOK 3,9M
-6%
Equity
NOK 1,2M
+0%
Employees
8
—
Company information
Legal name
TISTA SYNSSENTER AS
Org number
929263677
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
27. mai 2022
Share capital
NOK 60 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Optisk virksomhet som driver med synsundersøkelser, salg og tilpassing av briller, kontaktlinser og andre synshjelpemidler.
Contact
Address
Walkers Gate 4, 1771 Halden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of medical and orthopaedic goods
Companies in Halden
All Norway companies
Revenue
NOK millions
0M
4M
9M
13M
17M
13M
2022
13M
2023
14M
2024
15M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
1M
2025
Income statement
NOK thousands
Item
2022
2023
2024
2025
Revenue
13 141
13 303
13 726
14 654
Staff expenses
−3 915
−3 997
−4 112
−4 394
EBITDA
1 076
1 077
1 109
1 219
Depreciation & amort.
−329
−417
−386
−432
EBIT
747
659
723
787
Net financials
−42
−50
−2
22
Profit before tax
705
610
721
809
Tax
156
164
176
196
Net profit
549
446
545
613
Balance sheet
NOK thousands
Item
2022
2023
2024
2025
Total assets
4 111
4 290
4 199
3 940
Equity
108
1 266
1 191
1 194
Long-term debt
2 295
854
610
0
Short-term debt
1 707
2 170
2 398
2 380
Total debt
4 002
3 024
3 008
2 746
Financial ratios
5-year trend
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
2022
2025
Equity ratio
30.3%
This company
38.2%
Market median
+21% vs market
2022
2025
Return on equity
51.3%
This company
18.4%
Market median
+179% vs market
2022
2025
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
2022
2025
Asset turnover
3.72×
This company
1.12×
Market median
+232% vs market
2022
2025
Debt / equity
2.30×
This company
0.62×
Market median
-271% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KH
Karina Hesse
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JT
Jørn Torkel Seim
Chairman
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Hesse Holding As
Company
50%
50%
2024
Sesse Holding As
Company
50%
50%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Sesse Holding As
TISTA SYNSSENTER AS
(this company)
Board network connections
Board members of TISTA SYNSSENTER AS also hold positions in
0
other companies.
Person
Role here
Other companies
Karina Hesse
Chief Executive Officer
0 companies
Jørn Torkel Seim
Chairman
0 companies